Cargando…
Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report
Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and the current treatment for early-stage MPM is based on a multimodality therapy regimen involving platinum-based chemotherapy preceding or following surgery. To enhance the cytoreductive role of surgery, some peri- o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658521/ https://www.ncbi.nlm.nih.gov/pubmed/34884251 http://dx.doi.org/10.3390/jcm10235542 |
_version_ | 1784612752475553792 |
---|---|
author | Bongiolatti, Stefano Mazzoni, Francesca Salimbene, Ottavia Caliman, Enrico Ammatuna, Carlo Comin, Camilla E. Antonuzzo, Lorenzo Voltolini, Luca |
author_facet | Bongiolatti, Stefano Mazzoni, Francesca Salimbene, Ottavia Caliman, Enrico Ammatuna, Carlo Comin, Camilla E. Antonuzzo, Lorenzo Voltolini, Luca |
author_sort | Bongiolatti, Stefano |
collection | PubMed |
description | Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and the current treatment for early-stage MPM is based on a multimodality therapy regimen involving platinum-based chemotherapy preceding or following surgery. To enhance the cytoreductive role of surgery, some peri- or intra-operative intracavitary treatments have been developed, such as hyperthermic chemotherapy, but long-term results are weak. The aim of this study was to report the post-operative results and mid-term outcomes of our multimodal intention-to-treat pathway, including induction chemotherapy, followed by surgery and Hyperthermic Intraoperative THOracic Chemotherapy (HITHOC) in the treatment of early-stage epithelioid MPM. Since 2017, stage I or II epithelioid MPM patients have been inserted in a surgery-based multimodal approach comprising platinum-based induction chemotherapy, followed by pleurectomy and decortication (P/D) and HITHOC with cisplatin. The Kaplan–Meier method was used to estimate overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS). During the study period, n = 65 patients affected by MPM were evaluated by our institutional Multidisciplinary Tumour Board; n = 12 patients with stage I-II who had no progression after induction chemotherapy underwent P/D and HITHOC. Post-operative mortality was 0, and complications developed in n = 7 (58.3%) patients. The median estimated OS was 31 months with a 1-year and 3-year OS of 100% and 55%, respectively. The median PFS was 26 months with 92% of a 1-year PFS, whereas DFS was 19 months with a 1-year DFS rate of 83%. The multimodal treatment of early-stage epithelioid MPM, including induction chemotherapy followed by P/D and HITHOC, was well tolerated and feasible with promising mid-term oncological results. |
format | Online Article Text |
id | pubmed-8658521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86585212021-12-10 Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report Bongiolatti, Stefano Mazzoni, Francesca Salimbene, Ottavia Caliman, Enrico Ammatuna, Carlo Comin, Camilla E. Antonuzzo, Lorenzo Voltolini, Luca J Clin Med Article Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and the current treatment for early-stage MPM is based on a multimodality therapy regimen involving platinum-based chemotherapy preceding or following surgery. To enhance the cytoreductive role of surgery, some peri- or intra-operative intracavitary treatments have been developed, such as hyperthermic chemotherapy, but long-term results are weak. The aim of this study was to report the post-operative results and mid-term outcomes of our multimodal intention-to-treat pathway, including induction chemotherapy, followed by surgery and Hyperthermic Intraoperative THOracic Chemotherapy (HITHOC) in the treatment of early-stage epithelioid MPM. Since 2017, stage I or II epithelioid MPM patients have been inserted in a surgery-based multimodal approach comprising platinum-based induction chemotherapy, followed by pleurectomy and decortication (P/D) and HITHOC with cisplatin. The Kaplan–Meier method was used to estimate overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS). During the study period, n = 65 patients affected by MPM were evaluated by our institutional Multidisciplinary Tumour Board; n = 12 patients with stage I-II who had no progression after induction chemotherapy underwent P/D and HITHOC. Post-operative mortality was 0, and complications developed in n = 7 (58.3%) patients. The median estimated OS was 31 months with a 1-year and 3-year OS of 100% and 55%, respectively. The median PFS was 26 months with 92% of a 1-year PFS, whereas DFS was 19 months with a 1-year DFS rate of 83%. The multimodal treatment of early-stage epithelioid MPM, including induction chemotherapy followed by P/D and HITHOC, was well tolerated and feasible with promising mid-term oncological results. MDPI 2021-11-26 /pmc/articles/PMC8658521/ /pubmed/34884251 http://dx.doi.org/10.3390/jcm10235542 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bongiolatti, Stefano Mazzoni, Francesca Salimbene, Ottavia Caliman, Enrico Ammatuna, Carlo Comin, Camilla E. Antonuzzo, Lorenzo Voltolini, Luca Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title | Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title_full | Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title_fullStr | Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title_full_unstemmed | Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title_short | Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report |
title_sort | induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658521/ https://www.ncbi.nlm.nih.gov/pubmed/34884251 http://dx.doi.org/10.3390/jcm10235542 |
work_keys_str_mv | AT bongiolattistefano inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT mazzonifrancesca inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT salimbeneottavia inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT calimanenrico inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT ammatunacarlo inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT comincamillae inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT antonuzzolorenzo inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport AT voltoliniluca inductionchemotherapyfollowedbypleurectomydecorticationandhyperthermicintraoperativechemotherapyhithocforearlystageepitheliodmalignantpleuralmesotheliomaaprospectivereport |